Profile data is unavailable for this security.
About the company
Shanghai Bio-Heart Biological Technology Co Ltd is a China-based company mainly engaged in interventional instruments. The Company's main businesses are the development and production of interventional cardiovascular devices. The Company's main products include fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The Company's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension.
- Revenue in HKD (TTM)0.00
- Net income in HKD-190.36m
- Incorporated2014
- Employees32.00
- LocationShanghai Bio-heart Biological Technology Co LtdRoom 302, 3/F, Building 4No.590 Ruiqing Road, East ZhangjiangHi-Tech Park, Pudong New AreaSHANGHAI 2012201ChinaCHN
- Phone+86 2 168798511
- Fax+86 2 168798512
- Websitehttp://www.bio-heart.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elife Holdings Ltd | 177.84m | -15.57m | 274.63m | 63.00 | -- | 2.09 | -- | 1.54 | -0.0202 | -0.0202 | 0.2253 | 0.1161 | 1.87 | 64.30 | 11.32 | 4,041,909.00 | -19.54 | -46.05 | -17.05 | -43.71 | 4.11 | 2.86 | -10.45 | -44.18 | 1.40 | -- | 0.1211 | -- | 56.51 | 9.31 | 43.00 | -- | -70.90 | -- |
| Broncus Holding Corp | 80.13m | -219.49m | 305.77m | 308.00 | -- | 0.2111 | -- | 3.82 | -0.4493 | -0.4493 | 0.164 | 2.75 | 0.0491 | 0.6724 | 1.11 | 260,157.40 | -13.45 | -- | -14.00 | -- | 70.47 | -- | -273.93 | -- | 18.34 | -- | 0.0125 | -- | 8.95 | -- | -0.1962 | -- | -- | -- |
| Arts Optical International Holdings Ltd | 1.20bn | 51.32m | 320.60m | 3.70k | 6.25 | 0.5916 | 3.50 | 0.268 | 0.1329 | 0.1329 | 3.10 | 1.40 | 1.01 | 5.30 | 3.20 | 323,326.80 | 4.79 | -7.51 | 10.18 | -13.89 | 31.01 | 25.18 | 4.74 | -8.38 | 0.9219 | 73.32 | 0.0383 | -- | 4.56 | 0.005 | -55.28 | -- | 21.11 | -- |
| Austar Lifesciences Ltd | 1.91bn | -35.29m | 425.44m | 1.61k | -- | 0.5085 | 36.37 | 0.2229 | -0.0689 | -0.2396 | 3.72 | 1.63 | 0.7757 | 3.90 | 1.80 | 1,185,586.00 | -1.53 | 4.39 | -3.44 | 9.98 | 19.05 | 23.09 | -1.97 | 4.56 | 1.13 | -1.66 | 0.3902 | -- | -18.23 | 16.65 | -131.28 | -- | -- | -- |
| China Health Group Ltd | 74.43m | -29.50m | 440.68m | 133.00 | -- | 5.85 | -- | 5.92 | -0.0651 | -0.0651 | 0.1641 | 0.1572 | 0.2536 | 3.82 | 3.03 | 543,313.90 | -9.74 | -10.57 | -17.56 | -21.42 | 33.62 | 33.05 | -38.40 | -32.70 | 0.9156 | -4.91 | 0.0765 | -- | -28.60 | 25.81 | -244.50 | -- | 50.63 | -- |
| Shanghai Bio-heart Biologicl Tech Co Ltd | 0.00 | -190.36m | 522.03m | 32.00 | -- | 0.6445 | -- | -- | -0.7812 | -0.7812 | 0.00 | 3.32 | 0.00 | -- | -- | 0.00 | -20.99 | -- | -22.30 | -- | -- | -- | -- | -- | 20.16 | -- | 0.0023 | -- | -- | -- | 13.88 | -- | -- | -- |
| Ziyuanyuan Holdings Group Ltd | 538.91m | 15.76m | 675.10m | 184.00 | 39.84 | 1.86 | 22.15 | 1.25 | 0.0394 | 0.0394 | 1.35 | 0.8454 | 0.818 | 44.54 | 3.02 | 2,928,858.00 | 2.28 | 2.61 | 3.67 | 3.71 | 24.69 | -- | 2.78 | 6.13 | 1.75 | 2.26 | 0.313 | -- | 53.41 | 52.48 | -7.90 | -2.98 | -- | -- |
| Shanghai HeartCare Medcl Tech Corp Ltd | 251.45m | -101.74m | 751.83m | 368.00 | -- | 0.6458 | -- | 2.99 | -2.67 | -2.67 | 6.60 | 29.98 | 0.1849 | 0.4931 | 4.54 | 683,297.20 | -7.48 | -- | -7.88 | -- | 70.48 | -- | -40.46 | -- | 14.37 | -- | 0.0327 | -- | 26.94 | -- | 53.08 | -- | -- | -- |
Data as of May 10 2024. Currency figures normalised to Shanghai Bio-heart Biological Technology Co Ltd's reporting currency: Hong Kong Dollar HKD
1.68%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Snow Lake Management LPas of 15 Dec 2022 | 2.91m | 1.23% |
| OrbiMed Advisors LLCas of 22 Mar 2024 | 1.03m | 0.44% |
| China Asset Management (Hong Kong) Ltd.as of 31 Dec 2023 | 24.00k | 0.01% |
Data from 28 Sep 2023 - 09 May 2024Source: FactSet Research Systems Inc.
